We are live on ! Find out more
ORC

O'Rourke & Company Portfolio holdings

AUM $253M
1-Year Est. Return 16.72%
This Fund
S&P 500
This Quarter Est. Return
+6.88%
1 Year Est. Return
+16.72%
3 Year Est. Return
+62.38%
5 Year Est. Return
10 Year Est. Return
AUM
$126M
AUM Growth
+$11.4M
Cap. Flow
+$5M
Cap. Flow %
3.97%
Top 10 Hldgs %
38.37%
Holding
137
New
20
Increased
66
Reduced
38
Closed
4

Sector Composition

Rank Sector Weight
1 Financials 14.35%
2 Technology 13.7%
3 Healthcare 6.42%
4 Communication Services 3.19%
5 Consumer Staples 2.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VFH icon
26
Vanguard Financials ETF
VFH
$13.6B
$1.32M 1.05%
16,005
+416
+3% +$34.4K
PHO icon
27
Invesco Water Resources ETF
PHO
$2.03B
$1.29M 1.03%
25,109
+1,221
+5% +$61.6K
SCMB icon
28
Schwab Municipal Bond ETF
SCMB
$3.91B
$1.18M 0.94%
+46,006
New +$1.16M
KO icon
29
Coca-Cola
KO
$377B
$1.17M 0.92%
18,307
+358
+2% +$21.6K
WAT icon
30
Waters Corp
WAT
$37B
$1.12M 0.89%
3,282
-300
-8% -$94.9K
VBR icon
31
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.6B
$1.12M 0.89%
7,049
+2,856
+68% +$455K
PFE icon
32
Pfizer
PFE
$143B
$1.09M 0.87%
21,369
+2,165
+11% +$104K
WELL icon
33
Welltower
WELL
$169B
$990K 0.79%
15,110
-123
-0.8% -$7.91K
GSK icon
34
GSK
GSK
$104B
$961K 0.76%
27,356
+1,104
+4% +$36.8K
GS icon
35
Goldman Sachs
GS
$300B
$959K 0.76%
2,792
+140
+5% +$48.7K
IBB icon
36
iShares Biotechnology ETF
IBB
$9.18B
$888K 0.7%
6,761
+2
+0% +$258
VYM icon
37
Vanguard High Dividend Yield ETF
VYM
$81.4B
$888K 0.7%
8,209
+1,469
+22% +$156K
BLK icon
38
Blackrock
BLK
$169B
$869K 0.69%
1,226
-670
-35% -$447K
VB icon
39
Vanguard Morningstar Small-Cap ETF
VB
$80.7B
$863K 0.68%
4,701
+264
+6% +$48.9K
PG icon
40
Procter & Gamble
PG
$336B
$856K 0.68%
5,645
-221
-4% -$31K
DVY icon
41
iShares Select Dividend ETF
DVY
$23.6B
$837K 0.66%
6,937
+158
+2% +$18.7K
SPY icon
42
State Street SPDR S&P 500 ETF Trust
SPY
$806B
$817K 0.65%
2,137
+116
+6% +$44.6K
CIBR icon
43
First Trust NASDAQ Cybersecurity ETF
CIBR
$14.7B
$767K 0.61%
19,807
-25,791
-57% -$1.02M
VDE icon
44
Vanguard Energy ETF
VDE
$9.95B
$764K 0.61%
6,301
+1,113
+21% +$135K
XLV icon
45
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
$759K 0.6%
5,586
+21
+0.4% +$2.78K
MRK icon
46
Merck
MRK
$322B
$731K 0.58%
6,587
+491
+8% +$50.2K
XLP icon
47
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.8B
$714K 0.57%
9,578
+676
+8% +$49.3K
EBC icon
48
Eastern Bankshares
EBC
$5.26B
$692K 0.55%
40,089
+505
+1% +$9.66K
FTCS icon
49
First Trust Capital Strength ETF
FTCS
$7.86B
$686K 0.54%
9,155
-449
-5% -$33.1K
VO icon
50
Vanguard Morningstar Mid-Cap ETF
VO
$108B
$682K 0.54%
13,376
+8
+0.1% +$407

Similar funds

O'Rourke & Company's Q4 2022 Portfolio in Review

As of Q4 2022, O'Rourke & Company held 137 positions worth $126M, up 9.9% from $115M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

O'Rourke & Company deployed $5M of net new capital in Q4 2022, opening 20 new positions and adding to 66 existing holdings. Its largest new stake was Schwab Municipal Bond ETF: 46,006 shares worth $1.18M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was First Trust NASDAQ Cybersecurity ETF, an estimated $1.02M trimmed.

  • O'Rourke & Company's largest Q4 2022 buy was Schwab Municipal Bond ETF: 46,006 shares worth $1.18M.
  • O'Rourke & Company added most to JPMorgan Equity Premium Income ETF in Q4 2022, an estimated $845K increase.
  • O'Rourke & Company's biggest Q4 2022 reduction was First Trust NASDAQ Cybersecurity ETF, cutting an estimated $1.02M.
  • O'Rourke & Company fully exited M&T Bank in Q4 2022, selling an estimated $238K.
  • O'Rourke & Company's ten largest holdings make up 38% of its $126M portfolio in Q4 2022.
  • O'Rourke & Company opened 20 new positions and closed 4 in Q4 2022.
  • O'Rourke & Company's portfolio value rose 9.9% quarter-over-quarter to $126M.

Based on O'Rourke & Company's 13F filing for Q4 2022, filed 13 Feb 2023.